1
|
Lin MH, Kuo YT, Danglad-Flores J, Sletten ET, Seeberger PH. Parametric Analysis of Donor Activation for Glycosylation Reactions. Chemistry 2024; 30:e202400479. [PMID: 38545936 DOI: 10.1002/chem.202400479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2024] [Indexed: 04/18/2024]
Abstract
The chemical synthesis of complex oligosaccharides relies on efficient and highly reproducible glycosylation reactions. The outcome of a glycosylation is contingent upon several environmental factors, such as temperature, acidity, the presence of residual moisture, as well as the steric, electronic, and conformational aspects of the reactants. Each glycosylation proceeds rapidly and with a high yield within a rather narrow temperature range. For better control over glycosylations and to ensure fast and reliable reactions, a systematic analysis of 18 glycosyl donors revealed the effect of reagent concentration, water content, protecting groups, and structure of the glycosyl donors on the activation temperature. With these insights, we parametrize the first step of the glycosylation reaction to be executed reliably and efficiently.
Collapse
Affiliation(s)
- Mei-Huei Lin
- Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476, Potsdam, Germany
- Department of Chemistry and Biochemistry, Freie Universität Berlin, Arnimallee 22, 14195, Berlin, Germany
| | - Yan-Ting Kuo
- Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476, Potsdam, Germany
- Department of Chemistry and Biochemistry, Freie Universität Berlin, Arnimallee 22, 14195, Berlin, Germany
- GlycoUniverseGmbH&Co.KGaA, Am Mühlenberg 11, 14476, Potsdam, Germany
| | - José Danglad-Flores
- Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476, Potsdam, Germany
| | - Eric T Sletten
- Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476, Potsdam, Germany
| | - Peter H Seeberger
- Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476, Potsdam, Germany
- Department of Chemistry and Biochemistry, Freie Universität Berlin, Arnimallee 22, 14195, Berlin, Germany
| |
Collapse
|
2
|
Gamboa Marin OJ, Heis F, Gauthier C. Synthesis of immunostimulatory saponins: A sweet challenge for carbohydrate chemists. Carbohydr Res 2023; 530:108851. [PMID: 37257206 DOI: 10.1016/j.carres.2023.108851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2023] [Revised: 05/16/2023] [Accepted: 05/18/2023] [Indexed: 06/02/2023]
Abstract
Saponins are a large family of natural glycosides showing a wide range of biological activities. Current research efforts on saponins as vaccine adjuvants have been mainly focused on the development of synthetic analogs. By mimicking the immunomodulatory saponins from Quillaja saponaria (QS), less complex and readily accessible analogs have been synthesized to improve the industrial applicability and efficacy of saponins as vaccine adjuvants. Through the exploration of several structural modifications on the skeleton of QS saponins, including changes in the sugar and aglycone compositions as well as in the nature and configuration of the glycosidic bonds, structure-activity relationship (SAR) studies developed by Pr. Gin in the early 2010s were taken as a starting point for the development of a new generation of immunomodulatory candidates. In this review, the recent synthetic strategies and SAR studies of mono- and bidesmosidic QS saponins are discussed. Original concepts of vaccination including self-adjuvanticity and the development of saponin-based glycoconjugates are described. The synthesis and semi-synthesis of saponin alternatives to QS, such as Momordica saponin and onjisaponin derivatives, are also discussed in this review.
Collapse
Affiliation(s)
- Oscar Javier Gamboa Marin
- Unité mixte de recherche (UMR) INRS-UQAC, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval and Chicoutimi, Canada
| | - Floriane Heis
- Unité mixte de recherche (UMR) INRS-UQAC, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval and Chicoutimi, Canada
| | - Charles Gauthier
- Unité mixte de recherche (UMR) INRS-UQAC, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval and Chicoutimi, Canada.
| |
Collapse
|
3
|
Saponins of Selected Triterpenoids as Potential Therapeutic Agents: A Review. Pharmaceuticals (Basel) 2023; 16:ph16030386. [PMID: 36986485 PMCID: PMC10055990 DOI: 10.3390/ph16030386] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2023] [Revised: 02/15/2023] [Accepted: 02/24/2023] [Indexed: 03/06/2023] Open
Abstract
Saponins represent important natural derivatives of plant triterpenoids that are secondary plant metabolites. Saponins, also named glycoconjugates, are available both as natural and synthetic products. This review is focused on saponins of the oleanane, ursane, and lupane types of triterpenoids that include several plant triterpenoids displaying various important pharmacological effects. Additional convenient structural modifications of naturally-occurring plant products often result in enhancing the pharmacological effects of the parent natural structures. This is an important objective for all semisynthetic modifications of the reviewed plant products, and it is included in this review paper as well. The period covered by this review (2019–2022) is relatively short, mainly due to the existence of previously published review papers in recent years.
Collapse
|
4
|
Hussain N, Delar E, Piochon M, Groleau MC, Tebbji F, Sellam A, Déziel E, Gauthier C. Total synthesis of the proposed structures of gladiosides I and II. Carbohydr Res 2021; 507:108373. [PMID: 34157641 DOI: 10.1016/j.carres.2021.108373] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Revised: 06/07/2021] [Accepted: 06/07/2021] [Indexed: 10/21/2022]
Abstract
Burkholderia gladioli is a Gram-negative bacterium that biosynthesizes a cocktail of potent antimicrobial compounds, including the antifungal phenolic glycoside sinapigladioside. Herein, we report the total synthesis of the proposed structures of gladiosides I and II, two structurally related phenolic glycosides previously isolated from B. gladioli OR1 cultures. Importantly, the physical and analytical data of the synthetic compounds were in significant discrepancies with the natural products suggesting a misassignment of the originally proposed structures. Furthermore, we have uncovered an acid-catalyzed fragmentation mechanism converting the α,β-unsaturated methyl carbamate-containing gladioside II into the aldehyde-containing gladioside I. Our results lay the foundation for the expeditious synthesis of derivatives of these Burkholderia-derived phenolic glycosides, which would enable to decipher their biological roles and potential pharmacological properties.
Collapse
Affiliation(s)
- Nazar Hussain
- Centre Armand-Frappier Santé Biotechnologie, Institut National de La Recherche Scientifique (INRS), 531 Boulevard des Prairies, Laval (Québec), H7V 1B7, Canada
| | - Emmanilo Delar
- Centre Armand-Frappier Santé Biotechnologie, Institut National de La Recherche Scientifique (INRS), 531 Boulevard des Prairies, Laval (Québec), H7V 1B7, Canada
| | - Marianne Piochon
- Centre Armand-Frappier Santé Biotechnologie, Institut National de La Recherche Scientifique (INRS), 531 Boulevard des Prairies, Laval (Québec), H7V 1B7, Canada
| | - Marie-Christine Groleau
- Centre Armand-Frappier Santé Biotechnologie, Institut National de La Recherche Scientifique (INRS), 531 Boulevard des Prairies, Laval (Québec), H7V 1B7, Canada
| | - Faiza Tebbji
- Department of Microbiology, Infectious Disease and Immunology, Montreal Heart Institute, Université de Montréal, 5000 Rue Bélanger, Montréal (Québec), H1T 1C8, Canada
| | - Adnane Sellam
- Department of Microbiology, Infectious Disease and Immunology, Montreal Heart Institute, Université de Montréal, 5000 Rue Bélanger, Montréal (Québec), H1T 1C8, Canada
| | - Eric Déziel
- Centre Armand-Frappier Santé Biotechnologie, Institut National de La Recherche Scientifique (INRS), 531 Boulevard des Prairies, Laval (Québec), H7V 1B7, Canada
| | - Charles Gauthier
- Centre Armand-Frappier Santé Biotechnologie, Institut National de La Recherche Scientifique (INRS), 531 Boulevard des Prairies, Laval (Québec), H7V 1B7, Canada.
| |
Collapse
|